Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19... see more

TSXV:VXL - Post Discussion

Vaxil Bio Ltd > ------WHO IN THEIR RIGHT MIND---
View:
Post by threefiftynine on Jul 01, 2020 12:19pm

------WHO IN THEIR RIGHT MIND---

Is taking this GREED FILLED private placement if there isn't a POT of GOLD at the end of the rainbow-----CLOSE IT ASAP -!!!!!! and lets play CATCHUP before its too late as the aggression to find this POT of GOLD is beginning ---NOW -!!!!!----YA !!!!------ABSOLUTELY ! !!!!!!-------OR face a 03 cent stock and be the laughing stock of bio world --
Comment by threefiftynine on Jul 01, 2020 2:47pm
by @nasdaq on 28 Jan 2020, 10:15 Vaxil Announces Financing Update NESS-ZIONA, Israel, Jan. 28, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (Vaxil or the Company) (TSX VENTURE: VXL), an innovative immunotherapy biotech focused on cancer and infectious diseases, announces that the Company was not able to close the previously announced non-brokered private placement of up to 18,750,000 common shares ...more